Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukemia inhibitory factor enhances bone formation in calvarial bone defect.

S Dazai1, S Akita, A Hirano

  • 1Department of Plastic and Reconstructive Surgery, Atomic Disease Institute, Nagasaki University School of Medicine, Japan.

The Journal of Craniofacial Surgery
|April 21, 2001
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Spinal intradural arachnoid cyst associated with enlarged filum terminale].

No shinkei geka. Neurological surgery·1995
Same author

[A case of systemic lupus erythematosus associated with cerebral infarction and cerebral hemorrhage].

No to shinkei = Brain and nerve·1995
Same author

[A case of growing up aneurysms with occlusion of basilar artery].

No shinkei geka. Neurological surgery·1995
Same author

Craniofacial deformities associated with juvenile hyperthyroidism.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·1995
Same author

Expression and biological activities of bovine interleukin 4: effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro.

Cellular immunology·1995
Same author

[Combined hormone and chemotherapy for the patients with advanced prostate cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1995

Local delivery of Leukemia inhibitory factor (LIF) cDNA plasmid enhanced bone mineral density and promoted bone formation in rats. This cytokine therapy shows promise for bone defect reconstruction.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Orthopedic Surgery

Background:

  • Bone defect reconstruction remains a clinical challenge.
  • Leukemia inhibitory factor (LIF) is a cytokine known to promote osteogenesis.
  • Investigating novel delivery methods for osteogenic factors is crucial.

Purpose of the Study:

  • To evaluate the efficacy of locally administered Leukemia inhibitory factor (LIF) complementary deoxyribonucleic acid (cDNA) plasmid for bone defect reconstruction.
  • To assess the impact of LIF cDNA on bone mineral density and histological bone formation.
  • To compare LIF cDNA efficacy with recombinant human bone morphogenetic protein-2 (rhBMP-2).

Main Methods:

  • A total of 150 male Wistar rats were used, divided into three groups: control (gelatin carrier), LIF cDNA plasmid with gelatin carrier (three doses), and rhBMP-2.

Related Experiment Videos

  • Bone mineral density was measured using dual-energy X-ray absorptiometry (DEXA) at 1, 3, and 5 weeks post-operation.
  • Histological examination, in situ hybridization for LIF messenger ribonucleic acid (mRNA), and immunohistochemistry for LIF peptide were performed.

    • Main Results:

    • LIF cDNA treatment significantly enhanced bone mineral density within 3 weeks compared to the control group (p < 0.05).
    • Histological analysis revealed a decrease in fibroblast-like cells and collagen fibers, with a corresponding increase in osteoblast-like cells.
    • LIF mRNA and peptide were predominantly detected in osteocytes of the LIF cDNA-treated group.

    Conclusions:

    • Locally administered LIF cDNA plasmid in a gelatin carrier effectively increases bone density and promotes bone formation.
    • The mechanism likely involves osteocyte activation.
    • LIF cDNA represents a potential therapeutic agent for bone regeneration and defect repair.